A matched case-control study of Triple negative vs. HER-2 positive (irrespective of hormonal status) breast cancer: two subtypes with high risk features and poor outcome.
Zekri, J M
A matched case-control study of Triple negative vs. HER-2 positive (irrespective of hormonal status) breast cancer: two subtypes with high risk features and poor outcome. [electronic resource] - The Gulf journal of oncology Jan 2010 - 14-20 p. digital
Publication Type: Comparative Study; Journal Article
2078-2101
Adult
Biomarkers, Tumor--metabolism
Breast Neoplasms--metabolism
Case-Control Studies
Female
Humans
Immunoenzyme Techniques
Middle Aged
Neoplasm Staging
Neoplasms, Hormone-Dependent--metabolism
Prognosis
Receptor, ErbB-2--metabolism
Receptors, Estrogen--metabolism
Receptors, Progesterone--metabolism
Retrospective Studies
Risk Factors
A matched case-control study of Triple negative vs. HER-2 positive (irrespective of hormonal status) breast cancer: two subtypes with high risk features and poor outcome. [electronic resource] - The Gulf journal of oncology Jan 2010 - 14-20 p. digital
Publication Type: Comparative Study; Journal Article
2078-2101
Adult
Biomarkers, Tumor--metabolism
Breast Neoplasms--metabolism
Case-Control Studies
Female
Humans
Immunoenzyme Techniques
Middle Aged
Neoplasm Staging
Neoplasms, Hormone-Dependent--metabolism
Prognosis
Receptor, ErbB-2--metabolism
Receptors, Estrogen--metabolism
Receptors, Progesterone--metabolism
Retrospective Studies
Risk Factors